Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anti-inflammatory and analgesic drugs. Its structure supports modulation of biological activity, making it valuable in medicinal chemistry for designing compounds with improved metabolic stability and target selectivity. The presence of trifluoromethyl and hydroxyl groups enhances binding affinity and pharmacokinetic properties in drug candidates. Commonly employed in research settings for optimizing lead compounds in central nervous system and pain management therapies.